A Pilot Randomized Control Trial Testing a Smartphone-Delivered Food Attention Retraining Program in Adolescent Girls with Overweight or Obesity
- PMID: 39458453
- PMCID: PMC11510407
- DOI: 10.3390/nu16203456
A Pilot Randomized Control Trial Testing a Smartphone-Delivered Food Attention Retraining Program in Adolescent Girls with Overweight or Obesity
Abstract
Background/objectives: Attention bias (AB) toward food is associated with obesity, but it is unclear if programs designed to reduce AB can impact adolescents' eating behavior. We investigated whether a two-week, smartphone-delivered attention retraining (AR) program (vs a control program) altered food AB in adolescent girls with overweight.
Methods: Participants completed three food-cue visual-probe trainings/day. The AR and control programs directed attention away from food stimuli during 100% and 50% of trainings, respectively. Before and after completion of the programs, girls completed a food-cue visual-probe task while undergoing magnetoencephalography (MEG), and then a laboratory test meal.
Results: Sixty-eight adolescents were randomized; 58 completed post-program visits. There was minimal effect of condition on AB scores (β [95%CI] = -1.9 [-20.8, 16.9]; d = -0.06). There was a small effect of condition on energy intake (EMMcontrol = 1017 kcal, EMMAR = 1088 kcal, d = 0.29). Within the AR group, there was slightly blunted initial engagement in brain areas associated with reward response and subsequent increased goal-directed attention and action control.
Conclusions: We found preliminary support for efficacy of an intensive smartphone-delivered AR program to alter neural correlates of attention processing in adolescent girls with overweight or obesity. Studies with larger sample sizes are needed to elucidate if AR trainings disrupt the link between food AB and eating behavior.
Keywords: adolescence; attention bias; attention retraining; obesity; smartphone program.
Conflict of interest statement
The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. JAY receives grant support for unrelated studies sponsored by Rhythm Pharmaceuticals Inc., and Soleno Therapeutics Inc., colchicine and placebo supplied by Hikma Pharmaceuticals for an ongoing trial in people with obesity, and anti-Activin A receptor antibodies from Versanis Bio for studies in mice. The opinions and assertions expressed herein are those of the authors and are not to be construed as reflecting the views of the DHHS, USUHS, or the U.S. Department of Defense.
Figures




References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials